logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12202836 B1

PDFFull Text
Date of Patent:
Jan. 21, 2025

Filed:

Jun. 28, 2023

Bicyclic-fused heteroaryl or aryl compounds

Applicant:

Pfizer Inc., New York, NY (US);

Inventors:

John David Trzupek, Arlington, MA (US);

Katherine Lin Lee, West Newton, MA (US);

Mark Edward Bunnage, Concord, MA (US);

Seungil Han, Mystic, CT (US);

David Hepworth, Concord, MA (US);

Frank Eldridge Lovering, Acton, MA (US);

John Paul Mathias, Concord, MA (US);

Nikolaos Papaioannou, Newton, MA (US);

Betsy Susan Pierce, East Lyme, CT (US);

Joseph Walter Strohbach, Wentzville, MO (US);

Stephen Wayne Wright, Old Lyme, CT (US);

Christoph Wolfgang Zapf, Marlborough, MA (US);

Lori Krim Gavrin, Villanova, PA (US);

Arthur Lee, San Carlos, CA (US);

David Randolph Anderson, Salem, CT (US);

Kevin Joseph Curran, Somerset, NJ (US);

Christoph Martin Dehnhardt, Burnaby, CA;

Eddine Saiah, Brookline, MA (US);

Joel Adam Goldberg, New Orleans, LA (US);

Xiaolun Wang, San Diego, CA (US);

Horng-Chih Huang, Chesterfield, MO (US);

Richard Vargas, Bedford, MA (US);

Michael Dennis Lowe, White Plains, NY (US);

Akshay Patny, Waltham, MA (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:

A. David Joran

Primary Examiner:

Zinna Northington Davis

Int. Cl.
CPC ...
C07D 491/056 (2006.01); A61K 31/40 (2006.01); A61K 31/4015 (2006.01); A61K 31/47 (2006.01); A61K 31/4709 (2006.01); A61K 31/4725 (2006.01); A61K 31/517 (2006.01); A61K 31/5377 (2006.01); A61K 31/541 (2006.01); A61K 45/06 (2006.01); C07C 69/94 (2006.01); C07D 207/08 (2006.01); C07D 207/26 (2006.01); C07D 207/267 (2006.01); C07D 207/273 (2006.01); C07D 209/52 (2006.01); C07D 215/48 (2006.01); C07D 217/02 (2006.01); C07D 217/22 (2006.01); C07D 217/24 (2006.01); C07D 239/86 (2006.01); C07D 239/88 (2006.01); C07D 263/24 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 407/14 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); C07F 7/18 (2006.01);
U.S. Cl.
CPC ...
C07D 491/056 (2013.01); A61K 31/40 (2013.01); A61K 31/4015 (2013.01); A61K 31/47 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/517 (2013.01); A61K 31/5377 (2013.01); A61K 31/541 (2013.01); A61K 45/06 (2013.01); C07C 69/94 (2013.01); C07D 207/08 (2013.01); C07D 207/26 (2013.01); C07D 207/267 (2013.01); C07D 207/273 (2013.01); C07D 209/52 (2013.01); C07D 215/48 (2013.01); C07D 217/02 (2013.01); C07D 217/22 (2013.01); C07D 217/24 (2013.01); C07D 239/86 (2013.01); C07D 239/88 (2013.01); C07D 263/24 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 407/14 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01); C07F 7/1804 (2013.01);
Abstract

Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. In an embodiment, a pharmaceutical composition can be in a liquid dosage form and can comprise a therapeutically effective amount of the compound or a pharmaceutically acceptable salt thereof as an adjuvant and a therapeutic agent. In another embodiment, a method of adjuvant treating a disorder or condition can comprising administering the pharmaceutical composition to a patient.

Find Patent Forward Citations

Loading…